|
1
|
Nagai H and Kim YH: Cancer prevention from
the perspective of global cancer burden patterns. J Thorac Dis.
9:448–451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lagergren J, Smyth E, Cunningham D and
Lagergren P: Oesophageal cancer. Lancet. 390:2383–2396. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edgren G, Adami HO, Weiderpass Vainio E
and Nyrén O: A global assessment of the oesophageal adenocarcinoma
epidemic. Gut. 62:1406–1414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arnold M, Soerjomataram I, Ferlay J and
Forman D: Global incidence of oesophageal cancer by histological
subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang H, Fan JH and Qiao YL: Epidemiology,
etiology, and prevention of esophageal squamous cell carcinoma in
China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gavin AT, Francisci S, Foschi R, Donnelly
DW, Lemmens V, Brenner H and Anderson LA; EUROCARE-4 Working Group,
: Oesophageal cancer survival in Europe: A EUROCARE-4 study. Cancer
Epidemiol. 36:505–512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003–2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng HB, Zheng XG and Liu BP: miRNA-101
inhibits ovarian cancer cells proliferation and invasion by
down-regulating expression of SOCS-2. Int J Clin Exp Med.
8:20263–20270. 2015.PubMed/NCBI
|
|
13
|
Hua K, Yang W, Song H, Song J, Wei C, Li D
and Fang L: Up-regulation of miR-506 inhibits cell growth and
disrupt the cell cycle by targeting YAP in breast cancer cells. Int
J Clin Exp Med. 8:12018–12027. 2015.PubMed/NCBI
|
|
14
|
Guo Q, Zhang H, Zhang L, He Y, Weng S,
Dong Z, Wang J, Zhang P and Nao R: MicroRNA-21 regulates non-small
cell lung cancer cell proliferation by affecting cell apoptosis via
COX-19. Int J Clin Exp Med. 8:8835–8841. 2015.PubMed/NCBI
|
|
15
|
Brigant B, Metzinger-Le Meuth V, Massy ZA,
McKay N, Liabeuf S, Pelletier M, Sallée M, M'Baya-Moutoula E, Paul
P, Drueke TB, et al: Serum microRNAs are altered in various stages
of chronic kidney disease: A preliminary study. Clin Kidney J.
10:30–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Greene J, Baird AM, Brady L, Lim M, Gray
SG, McDermott R and Finn SP: Circular RNAs: Biogenesis, function
and role in human diseases. Front Mol Biosci. 4:382017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang Y, Fang DC and Hu JG: MicroRNA and
its roles in esophageal cancer. Med Sci Monit. 18:RA22–RA30. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu W, Pang L, Chen Y, Yang L, Zhu J and
Wei Y: The microRNAs as prognostic biomarkers for survival in
esophageal cancer: A meta-analysis. ScientificWorldJournal.
2014:5239792014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mathé EA, Nguyen GH, Bowman ED, Zhao Y,
Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et
al: MicroRNA expression in squamous cell carcinoma and
adenocarcinoma of the esophagus: Associations with survival. Clin
Cancer Res. 15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman and
Stoffel M: A pancreatic islet-specific microRNA regulates insulin
secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan JW, Lin JS and He XX: The emerging
role of miR-375 in cancer. Int J Cancer. 135:1011–1018. 2004.
View Article : Google Scholar
|
|
22
|
Xu L, Wen T, Liu Z, Xu F, Yang L, Liu J,
Feng G and An G: MicroRNA-375 suppresses human colorectal cancer
metastasis by targeting Frizzled 8. Oncotarget. 7:40644–40656.
2016.PubMed/NCBI
|
|
23
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Black AR, Black JD and Azizkhan-Clifford
J: Sp1 and krüppel-like factor family of transcription factors in
cell growth regulation and cancer. J Cell Physiol. 188:143–160.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karlseder J, Rotheneder H and
Wintersberger E: Interaction of Sp1 with the growth- and cell
cycle-regulated transcription factor E2F. Mol Cell Biol.
16:1659–1667. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo Z, Zhang W, Xia G, Niu L, Zhang Y,
Wang X, Zhang Y, Jiang B and Wang J: Sp1 upregulates the four and
half lim 2 (FHL2) expression in gastrointestinal cancers through
transcription regulation. Mol Carcinog. 49:826–836. 2010.PubMed/NCBI
|
|
27
|
Han D, Cho JH, Lee RH, Bang W, Park K, Kim
MS, Shim JH, Chae JI and Moon SY: Antitumorigenic effect of
atmospheric-pressure dielectric barrier discharge on human
colorectal cancer cells via regulation of Sp1 transcription factor.
Sci Rep. 7:430812017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deng R, Wu H, Ran H, Kong X, Hu L, Wang X
and Su Q: Glucose-derived AGEs promote migration and invasion of
colorectal cancer by up-regulating Sp1 expression. Biochim Biophys
Acta Gen Subj. 1861:1065–1674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang M, Linghu E, Zhan Q, He T, Cao B,
Brock MV, Herman JG, Xiang R and Guo M: Methylation of DACT2
accelerates esophageal cancer development by activating Wnt
signaling. Oncotarget. 7:17957–17969. 2016.PubMed/NCBI
|
|
32
|
Hu C, Lv L, Peng J, Liu D, Wang X, Zhou Y
and Huo J: microRNA-375 suppresses esophageal cancer cell growth
and invasion by repressing metadherin expression. Oncol Lett.
13:4769–4775. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Beishline K and Azizkhan-Clifford J: Sp1
and the ‘hallmarks of cancer’. FEBS J. 282:224–258. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan F, Mao H, Bu F, Tong X, Li J, Zhang S,
Liu X, Wang L, Wu L, Chen R, et al: Sp1-mediated transcriptional
activation of miR-205 promotes radioresistance in esophageal
squamous cell carcinoma. Oncotarget. 8:5735–5752. 2017.PubMed/NCBI
|
|
35
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and
Shi ZZ: miR-145-5p Suppresses tumor cell migration, invasion and
epithelial to mesenchymal transition by regulating the Sp1/NF-κB
signaling pathway in esophageal squamous cell carcinoma. Int J Mol
Sci. 18(pii): E18332017. View Article : Google Scholar : PubMed/NCBI
|
